Eli Lilly & Co’s experimental once-weekly diabetes drug dulaglutide proved superior in late-stage clinical trials to three other widely used medicines that are dosed more frequently, the company said on Monday.
Read more
Lilly’s dulaglutide tops 3 diabetes drugs in late-stage trials
Posted in Drugs Glucose & Insulin